Investigating how a specific microRNA affects tooth enamel formation
Role of miRNA from amelogenin exon4 in enamel formation
This study is looking at how certain genes affect the way tooth enamel is made, especially focusing on a tiny molecule that might help explain why some people have problems with their enamel, like in conditions such as amelogenesis imperfecta, so we can better understand these issues and their genetic roots.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10427352 on NIH RePORTER |
What this research studies
This research explores the genetic factors involved in the formation of tooth enamel, particularly focusing on a microRNA derived from a specific part of the amelogenin gene. The study aims to understand how this microRNA, which is produced when a certain exon is spliced out, influences the development of enamel-forming cells called ameloblasts. By examining the role of this microRNA in both normal and pathological enamel formation, the research seeks to uncover potential links to hereditary enamel defects, such as amelogenesis imperfecta. This could lead to a better understanding of enamel-related conditions and their underlying genetic causes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with hereditary enamel defects, such as amelogenesis imperfecta.
Not a fit: Patients without enamel defects or those whose conditions are unrelated to genetic factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights that lead to improved treatments for patients with enamel defects, enhancing their quality of life.
How similar studies have performed: While the role of microRNAs in tooth development is an emerging field, this specific investigation into miR-exon4 is novel and has not been extensively studied before.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Nakano, Yukiko — University of California, San Francisco
- Study coordinator: Nakano, Yukiko
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.